ArticleBioinformatics advances2026
dbcan-nf: a Nextflow pipeline for accurate CAZyme annotation in metagenomes.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Motivation: Carbohydrate-active enzymes (CAZymes) are crucial for carbohydrate degradation in any ecological environment. However, CAZyme annotation is not easy in whole-genome shotgun (WGS) metagenomes, due to the lack of accurate, scalable, robust, and reproducible workflows. We previously published dbCAN as a web server and associated standalone tool run_dbcan that performs CAZyme annotation with assembled genomes as the input but not with raw WGS reads. Results: Here, we present dbcan-nf, an accurate and scalable Nextflow pipeline integrating run_dbcan as a component step, for automated CAZyme annotation in metagenomes. dbcan-nf supports multiple analytical routes, including individual sample assembly (IA), multisample coassembly (CA), assembly-free (AF), and subsampling (SS), and accepts both short and long reads. Using five benchmark datasets, we showed that dbcan-nf (IA and AF routes) had a much higher accuracy (recall and F1 score) and detected more CAZyme families than the competing tool Cayman. Among the different routes, dbcan-nf-IA produced the most accurate CAZyme annotation, especially when the sequencing depth is sufficient (e.g., >1.0 Gb). However, as a read assembly-based method, dbcan-nf-IA had a higher computational cost than Cayman. Finally, dbcan-nf leverages Nextflow-supported high-performance computing execution for workflow-level scalability through concurrent processing of multiple samples. Availability and implementation: https://github.com/bcb-unl/dbcan-nf.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.